The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Rabies Diagnostics Market Research Report 2024

Global Rabies Diagnostics Market Research Report 2024

Publishing Date : May, 2024

License Type :
 

Report Code : 1719319

No of Pages : 96

Ask Your Query

Synopsis

Rabies is a viral disease that causes inflammation of the brain in humans and other mammals. Early symptoms can include fever and tingling at the site of exposure. These symptoms are followed by one or more of the following symptoms: violent movements, uncontrolled excitement, fear of water, an inability to move parts of the body, confusion, and loss of consciousness. Once symptoms appear, the result is nearly always death. The time period between contracting the disease and the start of symptoms is usually one to three months, but can vary from less than one week to more than one year. The time depends on the distance the virus must travel along peripheral nerves to reach the central nervous system.

The global Rabies Diagnostics market was valued at US$ 1740 million in 2023 and is anticipated to reach US$ 2128 million by 2030, witnessing a CAGR of 2.5% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Rabies Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rabies Diagnostics.

Report Scope

The Rabies Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rabies Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Rabies Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Bio-Rad Laboratories
  • Merck
  • Thermo Fisher
  • Roche
  • BioMerieux
  • QIAGEN
  • Agilent
  • Creative Diagnostics
  • Techne
  • Fluidigm
  • Abbexa Ltd
  • BioNote, Inc
  • Norgen Biotek Corp
  • Aviva Systems Biology
  • Demeditec Diagnostics GmbH
  • Express Biotech International

Segment by Type

  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Polymerase Chain Reaction (PCR) Assay
  • Others

Segment by Application

  • Hospitals
  • Diagnostic Centers
  • Public Health Labs
  • Home Care Setting

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rabies Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rabies Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Enzyme-Linked Immunosorbent Assay (ELISA)
1.2.3 Polymerase Chain Reaction (PCR) Assay
1.2.4 Others
1.3 Market by Application
1.3.1 Global Rabies Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Diagnostic Centers
1.3.4 Public Health Labs
1.3.5 Home Care Setting
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rabies Diagnostics Market Perspective (2019-2030)
2.2 Rabies Diagnostics Growth Trends by Region
2.2.1 Global Rabies Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Rabies Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Rabies Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Rabies Diagnostics Market Dynamics
2.3.1 Rabies Diagnostics Industry Trends
2.3.2 Rabies Diagnostics Market Drivers
2.3.3 Rabies Diagnostics Market Challenges
2.3.4 Rabies Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rabies Diagnostics Players by Revenue
3.1.1 Global Top Rabies Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Rabies Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Rabies Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Rabies Diagnostics Revenue
3.4 Global Rabies Diagnostics Market Concentration Ratio
3.4.1 Global Rabies Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rabies Diagnostics Revenue in 2023
3.5 Rabies Diagnostics Key Players Head office and Area Served
3.6 Key Players Rabies Diagnostics Product Solution and Service
3.7 Date of Enter into Rabies Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rabies Diagnostics Breakdown Data by Type
4.1 Global Rabies Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Rabies Diagnostics Forecasted Market Size by Type (2025-2030)
5 Rabies Diagnostics Breakdown Data by Application
5.1 Global Rabies Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Rabies Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Rabies Diagnostics Market Size (2019-2030)
6.2 North America Rabies Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Rabies Diagnostics Market Size by Country (2019-2024)
6.4 North America Rabies Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Rabies Diagnostics Market Size (2019-2030)
7.2 Europe Rabies Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Rabies Diagnostics Market Size by Country (2019-2024)
7.4 Europe Rabies Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rabies Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Rabies Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Rabies Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Rabies Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Rabies Diagnostics Market Size (2019-2030)
9.2 Latin America Rabies Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Rabies Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Rabies Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rabies Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Rabies Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Rabies Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Rabies Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio-Rad Laboratories
11.1.1 Bio-Rad Laboratories Company Detail
11.1.2 Bio-Rad Laboratories Business Overview
11.1.3 Bio-Rad Laboratories Rabies Diagnostics Introduction
11.1.4 Bio-Rad Laboratories Revenue in Rabies Diagnostics Business (2019-2024)
11.1.5 Bio-Rad Laboratories Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Rabies Diagnostics Introduction
11.2.4 Merck Revenue in Rabies Diagnostics Business (2019-2024)
11.2.5 Merck Recent Development
11.3 Thermo Fisher
11.3.1 Thermo Fisher Company Detail
11.3.2 Thermo Fisher Business Overview
11.3.3 Thermo Fisher Rabies Diagnostics Introduction
11.3.4 Thermo Fisher Revenue in Rabies Diagnostics Business (2019-2024)
11.3.5 Thermo Fisher Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Rabies Diagnostics Introduction
11.4.4 Roche Revenue in Rabies Diagnostics Business (2019-2024)
11.4.5 Roche Recent Development
11.5 BioMerieux
11.5.1 BioMerieux Company Detail
11.5.2 BioMerieux Business Overview
11.5.3 BioMerieux Rabies Diagnostics Introduction
11.5.4 BioMerieux Revenue in Rabies Diagnostics Business (2019-2024)
11.5.5 BioMerieux Recent Development
11.6 QIAGEN
11.6.1 QIAGEN Company Detail
11.6.2 QIAGEN Business Overview
11.6.3 QIAGEN Rabies Diagnostics Introduction
11.6.4 QIAGEN Revenue in Rabies Diagnostics Business (2019-2024)
11.6.5 QIAGEN Recent Development
11.7 Agilent
11.7.1 Agilent Company Detail
11.7.2 Agilent Business Overview
11.7.3 Agilent Rabies Diagnostics Introduction
11.7.4 Agilent Revenue in Rabies Diagnostics Business (2019-2024)
11.7.5 Agilent Recent Development
11.8 Creative Diagnostics
11.8.1 Creative Diagnostics Company Detail
11.8.2 Creative Diagnostics Business Overview
11.8.3 Creative Diagnostics Rabies Diagnostics Introduction
11.8.4 Creative Diagnostics Revenue in Rabies Diagnostics Business (2019-2024)
11.8.5 Creative Diagnostics Recent Development
11.9 Techne
11.9.1 Techne Company Detail
11.9.2 Techne Business Overview
11.9.3 Techne Rabies Diagnostics Introduction
11.9.4 Techne Revenue in Rabies Diagnostics Business (2019-2024)
11.9.5 Techne Recent Development
11.10 Fluidigm
11.10.1 Fluidigm Company Detail
11.10.2 Fluidigm Business Overview
11.10.3 Fluidigm Rabies Diagnostics Introduction
11.10.4 Fluidigm Revenue in Rabies Diagnostics Business (2019-2024)
11.10.5 Fluidigm Recent Development
11.11 Abbexa Ltd
11.11.1 Abbexa Ltd Company Detail
11.11.2 Abbexa Ltd Business Overview
11.11.3 Abbexa Ltd Rabies Diagnostics Introduction
11.11.4 Abbexa Ltd Revenue in Rabies Diagnostics Business (2019-2024)
11.11.5 Abbexa Ltd Recent Development
11.12 BioNote, Inc
11.12.1 BioNote, Inc Company Detail
11.12.2 BioNote, Inc Business Overview
11.12.3 BioNote, Inc Rabies Diagnostics Introduction
11.12.4 BioNote, Inc Revenue in Rabies Diagnostics Business (2019-2024)
11.12.5 BioNote, Inc Recent Development
11.13 Norgen Biotek Corp
11.13.1 Norgen Biotek Corp Company Detail
11.13.2 Norgen Biotek Corp Business Overview
11.13.3 Norgen Biotek Corp Rabies Diagnostics Introduction
11.13.4 Norgen Biotek Corp Revenue in Rabies Diagnostics Business (2019-2024)
11.13.5 Norgen Biotek Corp Recent Development
11.14 Aviva Systems Biology
11.14.1 Aviva Systems Biology Company Detail
11.14.2 Aviva Systems Biology Business Overview
11.14.3 Aviva Systems Biology Rabies Diagnostics Introduction
11.14.4 Aviva Systems Biology Revenue in Rabies Diagnostics Business (2019-2024)
11.14.5 Aviva Systems Biology Recent Development
11.15 Demeditec Diagnostics GmbH
11.15.1 Demeditec Diagnostics GmbH Company Detail
11.15.2 Demeditec Diagnostics GmbH Business Overview
11.15.3 Demeditec Diagnostics GmbH Rabies Diagnostics Introduction
11.15.4 Demeditec Diagnostics GmbH Revenue in Rabies Diagnostics Business (2019-2024)
11.15.5 Demeditec Diagnostics GmbH Recent Development
11.16 Express Biotech International
11.16.1 Express Biotech International Company Detail
11.16.2 Express Biotech International Business Overview
11.16.3 Express Biotech International Rabies Diagnostics Introduction
11.16.4 Express Biotech International Revenue in Rabies Diagnostics Business (2019-2024)
11.16.5 Express Biotech International Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Rabies Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Enzyme-Linked Immunosorbent Assay (ELISA)
Table 3. Key Players of Polymerase Chain Reaction (PCR) Assay
Table 4. Key Players of Others
Table 5. Global Rabies Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Rabies Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Rabies Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Rabies Diagnostics Market Share by Region (2019-2024)
Table 9. Global Rabies Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Rabies Diagnostics Market Share by Region (2025-2030)
Table 11. Rabies Diagnostics Market Trends
Table 12. Rabies Diagnostics Market Drivers
Table 13. Rabies Diagnostics Market Challenges
Table 14. Rabies Diagnostics Market Restraints
Table 15. Global Rabies Diagnostics Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Rabies Diagnostics Market Share by Players (2019-2024)
Table 17. Global Top Rabies Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rabies Diagnostics as of 2023)
Table 18. Ranking of Global Top Rabies Diagnostics Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Rabies Diagnostics Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Rabies Diagnostics Product Solution and Service
Table 22. Date of Enter into Rabies Diagnostics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Rabies Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Rabies Diagnostics Revenue Market Share by Type (2019-2024)
Table 26. Global Rabies Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Rabies Diagnostics Revenue Market Share by Type (2025-2030)
Table 28. Global Rabies Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Rabies Diagnostics Revenue Market Share by Application (2019-2024)
Table 30. Global Rabies Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Rabies Diagnostics Revenue Market Share by Application (2025-2030)
Table 32. North America Rabies Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Rabies Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Rabies Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Rabies Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Rabies Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Rabies Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Rabies Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Rabies Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Rabies Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Rabies Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Rabies Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Rabies Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Rabies Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Rabies Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Rabies Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 47. Bio-Rad Laboratories Company Detail
Table 48. Bio-Rad Laboratories Business Overview
Table 49. Bio-Rad Laboratories Rabies Diagnostics Product
Table 50. Bio-Rad Laboratories Revenue in Rabies Diagnostics Business (2019-2024) & (US$ Million)
Table 51. Bio-Rad Laboratories Recent Development
Table 52. Merck Company Detail
Table 53. Merck Business Overview
Table 54. Merck Rabies Diagnostics Product
Table 55. Merck Revenue in Rabies Diagnostics Business (2019-2024) & (US$ Million)
Table 56. Merck Recent Development
Table 57. Thermo Fisher Company Detail
Table 58. Thermo Fisher Business Overview
Table 59. Thermo Fisher Rabies Diagnostics Product
Table 60. Thermo Fisher Revenue in Rabies Diagnostics Business (2019-2024) & (US$ Million)
Table 61. Thermo Fisher Recent Development
Table 62. Roche Company Detail
Table 63. Roche Business Overview
Table 64. Roche Rabies Diagnostics Product
Table 65. Roche Revenue in Rabies Diagnostics Business (2019-2024) & (US$ Million)
Table 66. Roche Recent Development
Table 67. BioMerieux Company Detail
Table 68. BioMerieux Business Overview
Table 69. BioMerieux Rabies Diagnostics Product
Table 70. BioMerieux Revenue in Rabies Diagnostics Business (2019-2024) & (US$ Million)
Table 71. BioMerieux Recent Development
Table 72. QIAGEN Company Detail
Table 73. QIAGEN Business Overview
Table 74. QIAGEN Rabies Diagnostics Product
Table 75. QIAGEN Revenue in Rabies Diagnostics Business (2019-2024) & (US$ Million)
Table 76. QIAGEN Recent Development
Table 77. Agilent Company Detail
Table 78. Agilent Business Overview
Table 79. Agilent Rabies Diagnostics Product
Table 80. Agilent Revenue in Rabies Diagnostics Business (2019-2024) & (US$ Million)
Table 81. Agilent Recent Development
Table 82. Creative Diagnostics Company Detail
Table 83. Creative Diagnostics Business Overview
Table 84. Creative Diagnostics Rabies Diagnostics Product
Table 85. Creative Diagnostics Revenue in Rabies Diagnostics Business (2019-2024) & (US$ Million)
Table 86. Creative Diagnostics Recent Development
Table 87. Techne Company Detail
Table 88. Techne Business Overview
Table 89. Techne Rabies Diagnostics Product
Table 90. Techne Revenue in Rabies Diagnostics Business (2019-2024) & (US$ Million)
Table 91. Techne Recent Development
Table 92. Fluidigm Company Detail
Table 93. Fluidigm Business Overview
Table 94. Fluidigm Rabies Diagnostics Product
Table 95. Fluidigm Revenue in Rabies Diagnostics Business (2019-2024) & (US$ Million)
Table 96. Fluidigm Recent Development
Table 97. Abbexa Ltd Company Detail
Table 98. Abbexa Ltd Business Overview
Table 99. Abbexa Ltd Rabies Diagnostics Product
Table 100. Abbexa Ltd Revenue in Rabies Diagnostics Business (2019-2024) & (US$ Million)
Table 101. Abbexa Ltd Recent Development
Table 102. BioNote, Inc Company Detail
Table 103. BioNote, Inc Business Overview
Table 104. BioNote, Inc Rabies Diagnostics Product
Table 105. BioNote, Inc Revenue in Rabies Diagnostics Business (2019-2024) & (US$ Million)
Table 106. BioNote, Inc Recent Development
Table 107. Norgen Biotek Corp Company Detail
Table 108. Norgen Biotek Corp Business Overview
Table 109. Norgen Biotek Corp Rabies Diagnostics Product
Table 110. Norgen Biotek Corp Revenue in Rabies Diagnostics Business (2019-2024) & (US$ Million)
Table 111. Norgen Biotek Corp Recent Development
Table 112. Aviva Systems Biology Company Detail
Table 113. Aviva Systems Biology Business Overview
Table 114. Aviva Systems Biology Rabies Diagnostics Product
Table 115. Aviva Systems Biology Revenue in Rabies Diagnostics Business (2019-2024) & (US$ Million)
Table 116. Aviva Systems Biology Recent Development
Table 117. Demeditec Diagnostics GmbH Company Detail
Table 118. Demeditec Diagnostics GmbH Business Overview
Table 119. Demeditec Diagnostics GmbH Rabies Diagnostics Product
Table 120. Demeditec Diagnostics GmbH Revenue in Rabies Diagnostics Business (2019-2024) & (US$ Million)
Table 121. Demeditec Diagnostics GmbH Recent Development
Table 122. Express Biotech International Company Detail
Table 123. Express Biotech International Business Overview
Table 124. Express Biotech International Rabies Diagnostics Product
Table 125. Express Biotech International Revenue in Rabies Diagnostics Business (2019-2024) & (US$ Million)
Table 126. Express Biotech International Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rabies Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Rabies Diagnostics Market Share by Type: 2023 VS 2030
Figure 3. Enzyme-Linked Immunosorbent Assay (ELISA) Features
Figure 4. Polymerase Chain Reaction (PCR) Assay Features
Figure 5. Others Features
Figure 6. Global Rabies Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Rabies Diagnostics Market Share by Application: 2023 VS 2030
Figure 8. Hospitals Case Studies
Figure 9. Diagnostic Centers Case Studies
Figure 10. Public Health Labs Case Studies
Figure 11. Home Care Setting Case Studies
Figure 12. Rabies Diagnostics Report Years Considered
Figure 13. Global Rabies Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Rabies Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Rabies Diagnostics Market Share by Region: 2023 VS 2030
Figure 16. Global Rabies Diagnostics Market Share by Players in 2023
Figure 17. Global Top Rabies Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rabies Diagnostics as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Rabies Diagnostics Revenue in 2023
Figure 19. North America Rabies Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Rabies Diagnostics Market Share by Country (2019-2030)
Figure 21. United States Rabies Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Rabies Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Rabies Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Rabies Diagnostics Market Share by Country (2019-2030)
Figure 25. Germany Rabies Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Rabies Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Rabies Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Rabies Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Rabies Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Rabies Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Rabies Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Rabies Diagnostics Market Share by Region (2019-2030)
Figure 33. China Rabies Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Rabies Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Rabies Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Rabies Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Rabies Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Rabies Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Rabies Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Rabies Diagnostics Market Share by Country (2019-2030)
Figure 41. Mexico Rabies Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Rabies Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Rabies Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Rabies Diagnostics Market Share by Country (2019-2030)
Figure 45. Turkey Rabies Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Rabies Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Bio-Rad Laboratories Revenue Growth Rate in Rabies Diagnostics Business (2019-2024)
Figure 48. Merck Revenue Growth Rate in Rabies Diagnostics Business (2019-2024)
Figure 49. Thermo Fisher Revenue Growth Rate in Rabies Diagnostics Business (2019-2024)
Figure 50. Roche Revenue Growth Rate in Rabies Diagnostics Business (2019-2024)
Figure 51. BioMerieux Revenue Growth Rate in Rabies Diagnostics Business (2019-2024)
Figure 52. QIAGEN Revenue Growth Rate in Rabies Diagnostics Business (2019-2024)
Figure 53. Agilent Revenue Growth Rate in Rabies Diagnostics Business (2019-2024)
Figure 54. Creative Diagnostics Revenue Growth Rate in Rabies Diagnostics Business (2019-2024)
Figure 55. Techne Revenue Growth Rate in Rabies Diagnostics Business (2019-2024)
Figure 56. Fluidigm Revenue Growth Rate in Rabies Diagnostics Business (2019-2024)
Figure 57. Abbexa Ltd Revenue Growth Rate in Rabies Diagnostics Business (2019-2024)
Figure 58. BioNote, Inc Revenue Growth Rate in Rabies Diagnostics Business (2019-2024)
Figure 59. Norgen Biotek Corp Revenue Growth Rate in Rabies Diagnostics Business (2019-2024)
Figure 60. Aviva Systems Biology Revenue Growth Rate in Rabies Diagnostics Business (2019-2024)
Figure 61. Demeditec Diagnostics GmbH Revenue Growth Rate in Rabies Diagnostics Business (2019-2024)
Figure 62. Express Biotech International Revenue Growth Rate in Rabies Diagnostics Business (2019-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock